Too Many Unknowns In Preclinical Testing Of Percutaneous Valves – FDA
This article was originally published in The Gray Sheet
Executive Summary
FDA is encouraging collaboration among industry, clinicians and other experts to develop preclinical tests for percutaneous heart valve replacements
You may also be interested in...
St. Jude Unveils Plan To Launch Transcatheter Aortic Valve By 2012
St. Jude Medical plans to begin clinical trials of a transcatheter aortic heart valve system by the end of 2010, with the goal of earning a CE mark for European marketing in mid-2012
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.